Apex Healthcare Bhd
Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, ant… Read more
Apex Healthcare Bhd (7090) - Net Assets
Latest net assets as of September 2025: RM779.26 Million MYR
Based on the latest financial reports, Apex Healthcare Bhd (7090) has net assets worth RM779.26 Million MYR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM998.30 Million) and total liabilities (RM219.04 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RM779.26 Million |
| % of Total Assets | 78.06% |
| Annual Growth Rate | 11.41% |
| 5-Year Change | 68.73% |
| 10-Year Change | 174.17% |
| Growth Volatility | 17.03 |
Apex Healthcare Bhd - Net Assets Trend (2012–2024)
This chart illustrates how Apex Healthcare Bhd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Apex Healthcare Bhd (2012–2024)
The table below shows the annual net assets of Apex Healthcare Bhd from 2012 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | RM789.62 Million | -14.01% |
| 2023-12-31 | RM918.27 Million | +64.44% |
| 2022-12-31 | RM558.43 Million | +10.17% |
| 2021-12-31 | RM506.86 Million | +8.31% |
| 2020-12-31 | RM467.97 Million | +9.97% |
| 2019-12-31 | RM425.53 Million | +10.24% |
| 2018-12-31 | RM385.99 Million | +12.46% |
| 2017-12-31 | RM343.23 Million | +10.02% |
| 2016-12-31 | RM311.97 Million | +8.32% |
| 2015-12-31 | RM288.00 Million | +10.77% |
| 2014-12-31 | RM260.00 Million | +10.64% |
| 2013-12-31 | RM235.00 Million | +8.80% |
| 2012-12-31 | RM216.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Apex Healthcare Bhd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 296.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | RM633.91 Million | 80.28% |
| Common Stock | RM137.14 Million | 17.37% |
| Other Comprehensive Income | RM18.57 Million | 2.35% |
| Other Components | RM210.00 | 0.00% |
| Total Equity | RM789.62 Million | 100.00% |
Apex Healthcare Bhd Competitors by Market Cap
The table below lists competitors of Apex Healthcare Bhd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dimerco Express
TWO:5609
|
$248.24 Million |
|
Jilin Expressway Co Ltd
SHG:601518
|
$248.35 Million |
|
Kumba Iron Ore Ltd PK
PINK:KIROY
|
$248.39 Million |
|
Alpine Banks of Colorado
OTCQX:ALPIB
|
$248.47 Million |
|
PT Daya Intiguna Yasa Tbk
JK:MDIY
|
$248.15 Million |
|
Rocky Brands Inc
NASDAQ:RCKY
|
$248.12 Million |
|
Qingdao Topscomm Commun Inc
SHG:603421
|
$248.10 Million |
|
Ronshin Group A
SHE:301231
|
$248.06 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Apex Healthcare Bhd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 918,274,397 to 789,620,000, a change of -128,654,397 (-14.0%).
- Net income of 76,544,000 contributed positively to equity growth.
- Dividend payments of 205,130,000 reduced retained earnings.
- Share repurchases of 2,915,940 reduced equity.
- New share issuances of 2,916,000 increased equity.
- Other comprehensive income decreased equity by 3,937,731.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | RM76.54 Million | +9.69% |
| Dividends Paid | RM205.13 Million | -25.98% |
| Share Repurchases | RM2.92 Million | -0.37% |
| Share Issuances | RM2.92 Million | +0.37% |
| Other Comprehensive Income | RM-3.94 Million | -0.5% |
| Other Changes | RM3.87 Million | +0.49% |
| Total Change | RM- | -14.01% |
Book Value vs Market Value Analysis
This analysis compares Apex Healthcare Bhd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.36x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.92x to 2.36x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | RM0.67 | RM2.61 | x |
| 2017-12-31 | RM0.73 | RM2.61 | x |
| 2018-12-31 | RM0.82 | RM2.61 | x |
| 2019-12-31 | RM0.60 | RM2.61 | x |
| 2020-12-31 | RM0.66 | RM2.61 | x |
| 2021-12-31 | RM0.71 | RM2.61 | x |
| 2022-12-31 | RM0.78 | RM2.61 | x |
| 2023-12-31 | RM1.28 | RM2.61 | x |
| 2024-12-31 | RM1.10 | RM2.61 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Apex Healthcare Bhd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.69%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 7.96%
- • Asset Turnover: 0.95x
- • Equity Multiplier: 1.28x
- Recent ROE (9.69%) is below the historical average (15.84%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 11.79% | 6.45% | 1.35x | 1.35x | RM5.17 Million |
| 2016 | 11.20% | 6.01% | 1.39x | 1.34x | RM3.76 Million |
| 2017 | 12.95% | 7.17% | 1.36x | 1.33x | RM10.14 Million |
| 2018 | 15.18% | 8.98% | 1.21x | 1.40x | RM19.98 Million |
| 2019 | 12.41% | 7.66% | 1.18x | 1.37x | RM10.24 Million |
| 2020 | 11.97% | 8.02% | 1.13x | 1.33x | RM9.24 Million |
| 2021 | 11.72% | 7.71% | 1.13x | 1.34x | RM8.74 Million |
| 2022 | 18.08% | 11.50% | 1.18x | 1.33x | RM45.13 Million |
| 2023 | 43.34% | 42.51% | 0.83x | 1.22x | RM306.16 Million |
| 2024 | 9.69% | 7.96% | 0.95x | 1.28x | RM-2.42 Million |
Industry Comparison
This section compares Apex Healthcare Bhd's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $267,287,895
- Average return on equity (ROE) among peers: 15.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Apex Healthcare Bhd (7090) | RM779.26 Million | 11.79% | 0.28x | $248.22 Million |
| BCM Alliance Bhd (0187) | $46.58 Million | 17.66% | 0.67x | $2.53 Million |
| Pharmaniaga Bhd (7081) | $488.00 Million | 12.70% | 1.51x | $82.05 Million |